Remove Biotech Remove Globalization Remove Innovation
article thumbnail

Will enterprises soon keep their best gen AI use cases under wraps?

CIO

The victors may not be the greatest innovators, but they’ll be the best at protecting their innovations. A lot of this was incremental innovation around the user interface of coding assistants that developers have been using for 25 years,” says Sonnenblick.

Biotech 487
article thumbnail

Scaling a medical device company: A CIO’s digital transformation journey

CIO

Novanta is a leading global supplier of core technology solutions that give medical and advanced industrial original equipment manufacturers a competitive advantage. I’ve had many great positions throughout my career, in many different industries, from biotech to pharma to tech software companies, and currently at a medical device company.

Biotech 458
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

BCG & Hello Tomorrow Track Innovation in Deep Tech Using NetBase Quid

Netbasequid

In their paper on Deep Tech: The Great Wave of Innovation , BCG and Hello Tomorrow explain “what deep tech is, how it works, how different stakeholders can contribute to it, and how it can be harnessed for competitive advantage.” How patent intel can reveal emerging innovations. From here, the biotech world is your oyster.

Biotech 98
article thumbnail

Global Healthcare Industry – M&A and Capital Market Landscape Update

Evalueserve

Global Healthcare Market – 2021. However, the emergence of a Delta variant of COVID-19 in Europe, the US, and China is fueling the need for ‘booster shots’ to sustain global recovery. According to the IMF, the global economy is likely to grow by 5.9% Global Healthcare M&A: Unprecedented Fightback 2.0.

Capital 98
article thumbnail

Key Takeaways from J.P. Morgan’s 41st Annual Healthcare Conference?

Alpha Sense BI

Specifically, within the pharma and biotech sectors, there have been 22 deals announced so far in 2023 — again, a low number compared to the 70 made over the same period last year. Additionally, unprofitable biopharma, aka most biotech companies, is expected to invest $1.1 In 2021, Spinraza sales reached $1.9

Biotech 96
article thumbnail

Global Precision Medicine Market is Expected to Reach $216.75 billion by 2028

BIS Research

Precision medicine is an innovative approach to prevent and treat diseases by taking into account the individual distinction between genetic make-up, lifestyle, and environment of an individual. The global precision market by region is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

article thumbnail

Venture Capital Trends and Outlook for 2024

Alpha Sense BI

Instead, investors will likely turn to innovative start-up companies with promising growth plans and strong leadership teams. One VC sustainability investor in particular set forth a plan to reduce 10% of global carbon emissions by 2035 by investing in 100×100 companies.

Capital 52